3.29
price up icon1.54%   0.05
after-market Dopo l'orario di chiusura: 3.40 0.11 +3.34%
loading
Precedente Chiudi:
$3.24
Aprire:
$3.19
Volume 24 ore:
469.90K
Relative Volume:
5.24
Capitalizzazione di mercato:
$8.89M
Reddito:
-
Utile/perdita netta:
$-22.01M
Rapporto P/E:
-0.4985
EPS:
-6.6
Flusso di cassa netto:
$-18.31M
1 W Prestazione:
-13.19%
1M Prestazione:
+29.02%
6M Prestazione:
-45.62%
1 anno Prestazione:
-74.73%
Intervallo 1D:
Value
$2.93
$3.38
Intervallo di 1 settimana:
Value
$2.74
$4.81
Portata 52W:
Value
$1.39
$13.44

Vaccinex Inc Stock (VCNX) Company Profile

Name
Nome
Vaccinex Inc
Name
Telefono
585-271-2700
Name
Indirizzo
1895 MOUNT HOPE AVE, ROCHESTER, NY
Name
Dipendente
40
Name
Cinguettio
@Vaccinex
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
VCNX's Discussions on Twitter

Vaccinex Inc Stock (VCNX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2020-09-23 Downgrade BTIG Research Buy → Neutral
2018-09-04 Iniziato Ladenburg Thalmann Buy

Vaccinex Inc Borsa (VCNX) Ultime notizie

pulisher
09:44 AM

VCNXVaccinex, Inc. Latest Stock News & Market Updates - StockTitan

09:44 AM
pulisher
08:39 AM

Vaccinex Reports Improved Immunity Correlating with - GlobeNewswire

08:39 AM
pulisher
08:30 AM

Vaccinex Reports Improved Immunity Correlating with Clinical Benefit of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer’s Annual Meeting - StockTitan

08:30 AM
pulisher
Nov 01, 2024

Vaccinex reports progress in Alzheimer's treatment study By Investing.com - Investing.com Canada

Nov 01, 2024
pulisher
Nov 01, 2024

Vaccinex reports progress in Alzheimer's treatment study - Investing.com India

Nov 01, 2024
pulisher
Oct 31, 2024

Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 - GlobeNewswire

Oct 31, 2024
pulisher
Oct 31, 2024

Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference in Madrid, Spain - StockTitan

Oct 31, 2024
pulisher
Oct 28, 2024

Vaccinex stock tanks 40% despite positive Alzheimer’s study update - MSN

Oct 28, 2024
pulisher
Oct 25, 2024

Vaccinex Stock Spikes On 'Promising' Data On Alzheimer’s Drug Study: Retail Sentiment Brightens - Barchart

Oct 25, 2024
pulisher
Oct 24, 2024

Vaccinex to Report Promising New Efficacy Data for - GlobeNewswire

Oct 24, 2024
pulisher
Oct 24, 2024

Vaccinex to Report Promising New Efficacy Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference on October 31, 2024 - StockTitan

Oct 24, 2024
pulisher
Oct 20, 2024

Micron Technology (MU-Q) QuotePress Release - The Globe and Mail

Oct 20, 2024
pulisher
Oct 15, 2024

Orange Juice (OJX25) Quote - The Globe and Mail

Oct 15, 2024
pulisher
Oct 14, 2024

Antibody Library Technology Market Report to 2032 -AnaptysBio Inc, MorphoSys AG, XOMA Corporation, Abzena Plc, AvantGen – IndiaPolitics.com - IndiaPolitics.com

Oct 14, 2024
pulisher
Oct 09, 2024

Vaccinex faces potential Nasdaq delisting over equity shortfall - Investing.com India

Oct 09, 2024
pulisher
Oct 09, 2024

BTIG Research’s latest rating for VCNX stock - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

Vaccinex faces potential Nasdaq delisting over equity shortfall By Investing.com - Investing.com Canada

Oct 09, 2024
pulisher
Oct 09, 2024

Company’s Banking Shares: Up -90.42% from 52-Week Low, But Can the Momentum Hold? - The InvestChronicle

Oct 09, 2024
pulisher
Oct 09, 2024

Post-Trade Analysis: Vaccinex Inc (VCNX) Slides -27.92, Closing at 1.73 - The Dwinnex

Oct 09, 2024
pulisher
Oct 02, 2024

Vaccinex stock hits 52-week low at $2.98 amid market challenges - Investing.com

Oct 02, 2024
pulisher
Sep 25, 2024

Vaccinex stock hits 52-week low at $4.17 amid sharp annual decline - Investing.com Canada

Sep 25, 2024
pulisher
Sep 25, 2024

VSME’s price-to-free cash flow ratio: What it means for investors - US Post News

Sep 25, 2024
pulisher
Sep 25, 2024

Short Interest in Victory Square Technologies Inc. (OTCMKTS:VSQTF) Declines By 79.4% - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Viemed Healthcare, Inc. (NASDAQ:VMD) Shares Purchased by Victory Capital Management Inc. - Defense World

Sep 25, 2024
pulisher
Sep 24, 2024

WUXI BIO Buys back ~3.32M Shrs for ~$42.55M Ytd - AASTOCKS.com

Sep 24, 2024
pulisher
Sep 24, 2024

Vaxcyte Inc (PCVX) receives a Buy rating from Mizuho - Knox Daily

Sep 24, 2024
pulisher
Sep 24, 2024

Victrex plc (LON:VCT) Insider Jane Toogood Acquires 508 Shares - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

Victrex Director Buys Shares, Signals Confidence - TipRanks

Sep 24, 2024
pulisher
Sep 24, 2024

Bank of New York Mellon Corp Boosts Stock Holdings in Viemed Healthcare, Inc. (NASDAQ:VMD) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

StockNews.com Initiates Coverage on Vector Group (NYSE:VGR) - Defense World

Sep 24, 2024
pulisher
Sep 23, 2024

VICR Investors Have Opportunity to Lead Vicor Corporation Securities Fraud Lawsuit with the Schall Law Firm - Business Wire

Sep 23, 2024
pulisher
Sep 23, 2024

The Gross Law Firm Reminds Vicor Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 23, 2024VICR - PR Newswire

Sep 23, 2024
pulisher
Sep 23, 2024

Victory Capital Management Inc. Has $496,000 Stock Holdings in Zymeworks Inc. (NYSE:ZYME) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Rhumbline Advisers Has $1.01 Million Position in V2X, Inc. (NYSE:VVX) - Defense World

Sep 23, 2024
pulisher
Sep 21, 2024

Choreo LLC Takes Position in Vector Group Ltd. (NYSE:VGR) - Defense World

Sep 21, 2024
pulisher
Sep 20, 2024

VICOR 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Vicor CorporationVICR - Business Wire

Sep 20, 2024
pulisher
Sep 20, 2024

VICR FINAL DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, - GlobeNewswire

Sep 20, 2024
pulisher
Sep 20, 2024

First Eagle Investment Management LLC Purchases 2,067 Shares of V2X, Inc. (NYSE:VVX) - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Vaccinex issues new warrants, secures $6.2 million in funding - Investing.com

Sep 20, 2024
pulisher
Sep 20, 2024

Victory Capital Management Inc. Cuts Stake in Wyndham Hotels & Resorts, Inc. (NYSE:WH) - Defense World

Sep 20, 2024
pulisher
Sep 19, 2024

Vaccinex secures $6.2 million through warrant exercises By Investing.com - Investing.com Canada

Sep 19, 2024
pulisher
Sep 18, 2024

What's Going On With Vaccinex Stock Wednesday? - Benzinga

Sep 18, 2024
pulisher
Sep 18, 2024

Vaccinex secures $6.2 million through warrant exercises - Investing.com India

Sep 18, 2024
pulisher
Sep 18, 2024

Vaccinex Announces Exercise of Warrants for $6.2 Million in Gross Proceeds - GlobeNewswire

Sep 18, 2024
pulisher
Sep 15, 2024

(VCNX) Investment Report - Stock Traders Daily

Sep 15, 2024
pulisher
Sep 14, 2024

Vaccinex, Inc. (NASDAQ:VCNX) Sees Large Decline in Short Interest - Defense World

Sep 14, 2024
pulisher
Sep 13, 2024

Vaccinex Director Chrystyna Bedrij Stecyk Abruptly Resigns - TipRanks

Sep 13, 2024
pulisher
Aug 21, 2024

Vaccinex announces warrant cancellation option - Investing.com India

Aug 21, 2024
pulisher
Aug 20, 2024

Vaccinex announces warrant cancellation option By Investing.com - Investing.com Canada

Aug 20, 2024
pulisher
Aug 20, 2024

Vaccinex (VCNX) Extends Rally With New Clinical Insights - Stocks Telegraph

Aug 20, 2024
pulisher
Aug 18, 2024

VCNX (Vaccinex) Short-Term Debt & Capital Lease Obligation : $0.18 Mil (As of Mar. 2024) - GuruFocus.com

Aug 18, 2024

Vaccinex Inc Azioni (VCNX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):